ES521864A0 - Un procedimiento para la preparacion de derivados de areno y hetero-arenocarboxamidas - Google Patents
Un procedimiento para la preparacion de derivados de areno y hetero-arenocarboxamidasInfo
- Publication number
- ES521864A0 ES521864A0 ES521864A ES521864A ES521864A0 ES 521864 A0 ES521864 A0 ES 521864A0 ES 521864 A ES521864 A ES 521864A ES 521864 A ES521864 A ES 521864A ES 521864 A0 ES521864 A0 ES 521864A0
- Authority
- ES
- Spain
- Prior art keywords
- arenocarboxamides
- areno
- hetero
- derivatives
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8207217A FR2525595A1 (fr) | 1982-04-27 | 1982-04-27 | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
ES521864A0 true ES521864A0 (es) | 1984-08-01 |
ES8406419A1 ES8406419A1 (es) | 1984-08-01 |
Family
ID=9273433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521864A Expired ES8406419A1 (es) | 1982-04-27 | 1983-04-26 | Un procedimiento para la preparacion de derivados de areno y hetero-arenocarboxamidas |
Country Status (16)
Country | Link |
---|---|
US (1) | US4499094A (es) |
EP (1) | EP0094271B1 (es) |
JP (1) | JPS58201756A (es) |
AU (1) | AU555417B2 (es) |
CA (1) | CA1207324A (es) |
DE (1) | DE3365086D1 (es) |
DK (1) | DK184783A (es) |
ES (1) | ES8406419A1 (es) |
FR (1) | FR2525595A1 (es) |
GR (1) | GR77909B (es) |
HU (1) | HU189271B (es) |
IL (1) | IL68326A0 (es) |
MA (1) | MA19777A1 (es) |
NO (1) | NO831466L (es) |
PT (1) | PT76528B (es) |
ZA (1) | ZA832925B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2538388B1 (fr) * | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
FR2582514B1 (fr) * | 1985-05-30 | 1988-02-19 | Rhone Poulenc Sante | Medicaments a base d'amides, nouveaux amides et leur preparation |
HU196758B (en) * | 1986-05-21 | 1989-01-30 | Gyogyszerkutato Intezet | Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them |
WO1988002751A1 (en) * | 1986-10-13 | 1988-04-21 | Asahi Kasei Kogyo Kabushiki Kaisha | Pyridine derivatives |
EP0346841A3 (de) * | 1988-06-16 | 1991-01-09 | Ciba-Geigy Ag | 1-Aryl-naphthoesäureamide und diese enthaltende mikrobizide Mittel |
US5219864A (en) * | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5550124A (en) * | 1991-12-10 | 1996-08-27 | University Of Southern California | Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
IL117659A (en) * | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
KR20000048847A (ko) | 1996-10-01 | 2000-07-25 | 스즈키 다다시 | 미토콘드리아 막 안정화제 |
US6340704B1 (en) | 1997-04-25 | 2002-01-22 | Takeda Chemical Industries, Ltd. | Cell differentiation inducing amide derivatives, their production and use |
WO1998049900A1 (en) * | 1997-05-07 | 1998-11-12 | Emory University | Haloisoquinoline carboxamide |
ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
FR2778564B1 (fr) * | 1998-05-13 | 2001-07-13 | Sanofi Sa | Utilisation de composes reduisant l'apoptose |
WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
ES2246588T3 (es) * | 1998-12-18 | 2006-02-16 | Scios Inc. | Tratamiento de enfermedades que implican formacion de quistes. |
GB0516723D0 (en) * | 2005-08-15 | 2005-09-21 | Novartis Ag | Organic compounds |
EP2061764B1 (en) | 2006-08-22 | 2014-07-02 | Technion Research & Development Foundation LTD. | Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
WO2008063625A2 (en) * | 2006-11-20 | 2008-05-29 | Adolor Corporation | Pyridine compounds and methods of their use |
WO2009057528A1 (ja) * | 2007-10-31 | 2009-05-07 | Riken | 創薬のためのpetスクリーニング用分子プローブを製造するためのキット |
GB0907284D0 (en) | 2009-04-28 | 2009-06-10 | Queen Mary & Westfield College | Compounds for inducing cellular apoptosis |
WO2014164678A1 (en) * | 2013-03-12 | 2014-10-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Translocator protein imaging agents; methods of manufacture, and methods of use thereof |
US10035780B2 (en) | 2014-04-23 | 2018-07-31 | Technion Research & Development Foundation Ltd. | Quinazoline scaffold based compounds, pharmaceutical compositions and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1069296A (en) * | 1912-07-31 | 1913-08-05 | Hoechst Ag | Derivatives of phenylcinchoninic acid. |
BE764299A (en) * | 1971-03-12 | 1971-08-16 | Malesci Sas | Antifibrillatory ethylenediamines or imida- - zolines |
FR2417512A1 (fr) * | 1978-02-17 | 1979-09-14 | Parcor | Thieno (3,2-c) et thieno (2,3-c) pyridines, leur procede de preparation et leur application en therapeutique |
FR2485014A1 (fr) * | 1980-06-20 | 1981-12-24 | Pharmindustrie | Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments |
-
1982
- 1982-04-27 FR FR8207217A patent/FR2525595A1/fr active Granted
-
1983
- 1983-03-30 GR GR70936A patent/GR77909B/el unknown
- 1983-04-05 US US06/482,082 patent/US4499094A/en not_active Expired - Fee Related
- 1983-04-07 IL IL68326A patent/IL68326A0/xx unknown
- 1983-04-08 PT PT76528A patent/PT76528B/pt unknown
- 1983-04-14 CA CA000425918A patent/CA1207324A/fr not_active Expired
- 1983-04-15 DE DE8383400749T patent/DE3365086D1/de not_active Expired
- 1983-04-15 EP EP83400749A patent/EP0094271B1/fr not_active Expired
- 1983-04-25 MA MA19997A patent/MA19777A1/fr unknown
- 1983-04-26 NO NO831466A patent/NO831466L/no unknown
- 1983-04-26 JP JP58073653A patent/JPS58201756A/ja active Granted
- 1983-04-26 ZA ZA832925A patent/ZA832925B/xx unknown
- 1983-04-26 DK DK184783A patent/DK184783A/da not_active Application Discontinuation
- 1983-04-26 ES ES521864A patent/ES8406419A1/es not_active Expired
- 1983-04-26 HU HU831431A patent/HU189271B/hu unknown
- 1983-04-27 AU AU14002/83A patent/AU555417B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DK184783A (da) | 1983-10-28 |
FR2525595A1 (fr) | 1983-10-28 |
ZA832925B (en) | 1984-01-25 |
FR2525595B1 (es) | 1985-03-22 |
MA19777A1 (fr) | 1983-12-31 |
CA1207324A (fr) | 1986-07-08 |
PT76528A (fr) | 1983-05-01 |
GR77909B (es) | 1984-09-25 |
HU189271B (en) | 1986-06-30 |
JPH0324467B2 (es) | 1991-04-03 |
DK184783D0 (da) | 1983-04-26 |
US4499094A (en) | 1985-02-12 |
EP0094271A3 (en) | 1984-07-04 |
PT76528B (fr) | 1985-12-09 |
NO831466L (no) | 1983-10-28 |
JPS58201756A (ja) | 1983-11-24 |
ES8406419A1 (es) | 1984-08-01 |
IL68326A0 (en) | 1983-07-31 |
AU555417B2 (en) | 1986-09-25 |
EP0094271A2 (fr) | 1983-11-16 |
AU1400283A (en) | 1983-11-03 |
DE3365086D1 (en) | 1986-09-11 |
EP0094271B1 (fr) | 1986-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES551282A0 (es) | Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno | |
ES521864A0 (es) | Un procedimiento para la preparacion de derivados de areno y hetero-arenocarboxamidas | |
ES524946A0 (es) | Un procedimiento para la preparacion de derivados de benzoisotiazol y benzoisoxazol piperazina | |
ES534114A0 (es) | Procedimiento para la preparacion de nuevas n-alcoxi y n-alquil-sulfonilaminosulfonilureas | |
ES540812A0 (es) | Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno | |
ES530593A0 (es) | Un procedimiento para la preparacion de nuevos derivados de daunorrubicina y doxorrubicina | |
ES531659A0 (es) | Un procedimiento para la preparacion de nuevos derivados de arilamida | |
ES541229A0 (es) | Un procedimiento para la preparacion de nuevos derivados delcromano | |
ES535980A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina | |
AR231279A1 (es) | Un procedimiento para la preparacion de 2-2-benoil-3-mercaptopropionil amino-4-metiltio-butanoles quirales y acidos 2-2-bencil-3-metilmercaptopropionilamino-4-metil-tiobutiricos quirales | |
ES543646A0 (es) | Un procedimiento para la preparacion de derivados esteroida-les | |
ES544140A0 (es) | Un procedimiento para la preparacion de nuevos derivados de benzotiazina | |
ES524399A0 (es) | Un procedimiento para la preparacion de derivados de milbenicina d | |
ES534186A0 (es) | Un procedimiento para la preparacion de derivados peptidicos | |
ES530668A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos | |
ES532172A0 (es) | Un procedimiento para la preparacion de derivados de pirimidona | |
ES526130A0 (es) | Un procedimiento para la preparacion de derivados vinilacetamido oxacefalosporina | |
ES530973A0 (es) | Un procedimiento para la preparacion de benzoquinolicinas | |
ES540340A0 (es) | Un procedimiento para la preparacion de derivados de piperi-dina | |
ES535392A0 (es) | Un procedimiento para la preparacion de derivados de imidazobenzodiacepina | |
ES527804A0 (es) | Un procedimiento para la preparacion de derivados de oxacefalosporina | |
ES545776A0 (es) | Un procedimiento para la preparacion de nuevos derivados de feniletanamina | |
ES533496A0 (es) | Un procedimiento para la preparacion de tiazol y tiazin-bencimidazoles | |
ES522884A0 (es) | "un procedimiento para la preparacion de derivados de hidroxiimino y alcoxiimino de 1,4-dihidropiridina" | |
ES531498A0 (es) | Un procedimiento para la preparacion de derivados de pirimidinatriona |